The present invention relates to compositions and methods for inhibiting the release and/or biological activity of migration inhibitory factor (MIF). In particular, the invention relates to the uses of such compositions and methods for the treatment of various conditions involving cytokine-mediated toxicity, which include, but are not limited to shock, inflammation, graft versus host disease, and/or autoimmune diseases.

 
Web www.patentalert.com

< Method of isolating human neuroepithelial precursor cells from human fetal tissue

> Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors

> Immunointeractive molecules

~ 00513